Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical Materials (Bristol) is Scopus-indexed (Q2, CiteScore 6.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by IOP Publishing Ltd..
Checked against the index lists dated .
ISSN 1748-6041Verify ISSN ↗1748-605XVerify ISSN ↗
Publisher: IOP Publishing Ltd.
Cost to publish: About US$3,325 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 120 / 342 | 65th | Q2 |
| Biomaterials | 64 / 146 | 56th | Q2 |
| Bioengineering | 76 / 168 | 55th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q2, CiteScore 6.2.
Biomedical Materials (Bristol) is Q2 in Biomedical Engineering (rank 120 of 342), Q2 in Biomaterials (rank 64 of 146) and Q2 in Bioengineering (rank 76 of 168), by CiteScore 2025.
Biomedical Materials (Bristol) is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.2, which places it in quartile Q2 at the 65th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.620, quartile Q2, with an H-index of 99.
The publisher lists an article processing charge of about US$3,325 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biomedical Materials (Bristol) is published by IOP Publishing Ltd. Its print ISSN is 1748-6041 and its online ISSN is 1748-605X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomedical Materials (Bristol) has an h-index of 107 and a 2-year mean of 4.13 citations per paper (OpenAlex). Its Scopus CiteScore is 6.2, quartile Q2. On 2-year citations it ranks #103 of 322 Scopus journals in Biomedical Engineering.
Biomedical Materials (Bristol) published 206 papers in 2025; its busiest recent year was 2024 with 314. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from China (42.4%), United States (7.6%) and India (5.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 14 retracted papers are recorded (4.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.